Filing search / Inhibrx Biosciences, Inc. / "Assurance"

DEFM14A

INBX Inhibrx Biosciences, Inc.

26 Apr 24

Proxy related to merger

4:06pm

by law. The Company does not give any assurance that it will achieve its expectations. You should read this proxy statement and the documents that we … . Accordingly, if the Merger and the Spin-Off are not completed, there can be no assurance as to the effect of these risks and opportunities on the future

DEFA14A

yt1 cg5s381yja5w

6 Feb 24

Additional proxy soliciting materials

4:30pm

DEFA14A

rsd6ut74lo15s4

23 Jan 24

Additional proxy soliciting materials

5:25pm

DEFA14A

ly0df8p7t5

23 Jan 24

Additional proxy soliciting materials

6:38am

8-K

EX-99.1

k67z9qgzgaqwv3ho3

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

ro3tt9r

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

EX-2.1

ah6ius xi0

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

EX-2.2

r5rluab

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

8-K

EX-10.1

ch4vte

29 Aug 23

Inhibrx Announces $200 Million Private Placement Financing

9:03am